Predictors of left ventricular hypertrophy and their cutoffs in peritoneal dialysis patients

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Cardiovascular complications are a leading cause of death in peritoneal dialysis (PD) patients.
• Left ventricular hypertrophy (LVH) is a significant predictor of cardiovascular events in this population.
• Identifying modifiable risk factors for LVH in PD patients is crucial for improving outcomes.

Purpose of the Study:

• To identify risk factors associated with LVH in patients undergoing maintenance PD.
• To determine specific cutoffs for these risk factors that predict LVH development.
• To inform strategies for preventing cardiovascular complications in PD patients.

Main Methods:

• A cross-sectional study involving 38 stable PD patients on maintenance PD for at least 24 months.
• Evaluation of 23 variables including clinical parameters, biochemical markers, and inflammatory markers.
• Logistic regression and receiver operating characteristic (ROC) analysis to identify predictors and their cutoffs for LVH.

Main Results:

• LVH was prevalent in 57.9% of the studied PD patients.
• Significant predictors of LVH included HbA1c, peritoneal glucose load index (PGLI), fluid overload (FO), plasma brain natriuretic peptide (BNP), hsCRP, and IL-6.
• Specific cutoffs were identified: HbA1c (7.5%), PGLI (3.2 g/kg/day), FO (1.7 L), BNP (330 pg/mL), hsCRP (7.5 mg/dL), and IL-6 (3.3 pg/mL).

Conclusions:

• Reducing peritoneal glucose load (PGL) and improving hydration status are key to mitigating LVH risk.
• Attenuating inflammatory processes is essential for preventing LVH in PD patients.
• These findings support targeted interventions to decrease the incidence of LVH and associated cardiovascular events in PD.